BIOMAT Database Logo BIOMAT Database Logo

The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma. 2020

Ning Liu, and Wei Guo, and Qiancheng Shi, and Wenyuan Zhuang, and Xiaohong Pu, and Shaoyu Chen, and Feng Qu, and Linfeng Xu, and Xiaozhi Zhao, and Xiaogong Li, and Gutian Zhang, and Hongqian Guo, and Weidong Gan, and Dongmei Li
Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.

NONO-TFE3 RCC is a subtype of Xp11.2 translocation renal cell carcinoma (RCC). So far, only a small amount of NONO-TFE3 RCC have been reported owing to lack of effective diagnosis methods. Utilizing the novel dual-fusion fluorescence in situ hybridization (FISH) probe reported here, 5 cases of NONO-TFE3 RCC were identified and were ultimately confirmed by RT-PCR. Histopathology, all 5 cases were consisted by sheets of epithelial cells and papillary architecture. The cytoplasm was abundantly clear, and nucleoli was not prominent. Besides, the nuclear palisading, subnuclear vacuoles and psammoma bodies were identified. The most distinctive features were strong positive TFE3 staining but equivocal split signals of the TFE3 probe, which might lead to the misdiagnosis of Xp11.2 translocation RCC. The median age and median tumor size of the five patients were 41.2 years and 3.6 cm, respectively. A median following follow-up of 27 months showed moderate disease progression and prognosis in NONO-TFE3 RCC patients. In conclusion, the present study demonstrates the effectiveness and reliability of the NONO-TFE3 dual-fusion FISH probe for diagnosing NONO-TFE3 RCC. Suspected cases of Xp11.2 translocation RCC showing biphasic pattern, strong positive TFE3 staining, and equivocal split signals in the TFE3 FISH assay indicated a possibility of NONO-TFE3 RCC.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Ning Liu, and Wei Guo, and Qiancheng Shi, and Wenyuan Zhuang, and Xiaohong Pu, and Shaoyu Chen, and Feng Qu, and Linfeng Xu, and Xiaozhi Zhao, and Xiaogong Li, and Gutian Zhang, and Hongqian Guo, and Weidong Gan, and Dongmei Li
NONO-TFE3 Fusion Promotes Aerobic Glycolysis and Angiogenesis by Targeting HIF1A in NONO-TFE3 Translocation Renal Cell Carcinoma.
January 2021, Current cancer drug targets,
Ning Liu, and Wei Guo, and Qiancheng Shi, and Wenyuan Zhuang, and Xiaohong Pu, and Shaoyu Chen, and Feng Qu, and Linfeng Xu, and Xiaozhi Zhao, and Xiaogong Li, and Gutian Zhang, and Hongqian Guo, and Weidong Gan, and Dongmei Li
[Renal cell carcinoma associated with Xp11.2 translocation/NONO-TFE3 gene fusion: report of a case].
May 2018, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Ning Liu, and Wei Guo, and Qiancheng Shi, and Wenyuan Zhuang, and Xiaohong Pu, and Shaoyu Chen, and Feng Qu, and Linfeng Xu, and Xiaozhi Zhao, and Xiaogong Li, and Gutian Zhang, and Hongqian Guo, and Weidong Gan, and Dongmei Li
Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.
May 2015, Medicine,
Ning Liu, and Wei Guo, and Qiancheng Shi, and Wenyuan Zhuang, and Xiaohong Pu, and Shaoyu Chen, and Feng Qu, and Linfeng Xu, and Xiaozhi Zhao, and Xiaogong Li, and Gutian Zhang, and Hongqian Guo, and Weidong Gan, and Dongmei Li
Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement.
March 2017, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Ning Liu, and Wei Guo, and Qiancheng Shi, and Wenyuan Zhuang, and Xiaohong Pu, and Shaoyu Chen, and Feng Qu, and Linfeng Xu, and Xiaozhi Zhao, and Xiaogong Li, and Gutian Zhang, and Hongqian Guo, and Weidong Gan, and Dongmei Li
The positive regulation loop between NRF1 and NONO-TFE3 fusion promotes phase separation and aggregation of NONO-TFE3 in NONO-TFE3 tRCC.
April 2021, International journal of biological macromolecules,
Ning Liu, and Wei Guo, and Qiancheng Shi, and Wenyuan Zhuang, and Xiaohong Pu, and Shaoyu Chen, and Feng Qu, and Linfeng Xu, and Xiaozhi Zhao, and Xiaogong Li, and Gutian Zhang, and Hongqian Guo, and Weidong Gan, and Dongmei Li
A Simplified Diagnostic Approach on TFE3 Gene Fusion-Associated Renal Cell Carcinoma.
November 2020, Archives of pathology & laboratory medicine,
Ning Liu, and Wei Guo, and Qiancheng Shi, and Wenyuan Zhuang, and Xiaohong Pu, and Shaoyu Chen, and Feng Qu, and Linfeng Xu, and Xiaozhi Zhao, and Xiaogong Li, and Gutian Zhang, and Hongqian Guo, and Weidong Gan, and Dongmei Li
Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma.
October 1997, Oncogene,
Ning Liu, and Wei Guo, and Qiancheng Shi, and Wenyuan Zhuang, and Xiaohong Pu, and Shaoyu Chen, and Feng Qu, and Linfeng Xu, and Xiaozhi Zhao, and Xiaogong Li, and Gutian Zhang, and Hongqian Guo, and Weidong Gan, and Dongmei Li
Xp11.2 translocation renal neoplasm with features of TFE3 rearrangement associated renal cell carcinoma and Xp11 translocation renal mesenchymal tumor with melanocytic differentiation harboring NONO-TFE3 fusion gene.
September 2019, Pathology, research and practice,
Ning Liu, and Wei Guo, and Qiancheng Shi, and Wenyuan Zhuang, and Xiaohong Pu, and Shaoyu Chen, and Feng Qu, and Linfeng Xu, and Xiaozhi Zhao, and Xiaogong Li, and Gutian Zhang, and Hongqian Guo, and Weidong Gan, and Dongmei Li
A renal cell carcinoma with EWSR1-TFE3 fusion gene.
May 2020, Genes, chromosomes & cancer,
Ning Liu, and Wei Guo, and Qiancheng Shi, and Wenyuan Zhuang, and Xiaohong Pu, and Shaoyu Chen, and Feng Qu, and Linfeng Xu, and Xiaozhi Zhao, and Xiaogong Li, and Gutian Zhang, and Hongqian Guo, and Weidong Gan, and Dongmei Li
NONO::TFE3 fusion cutaneous epithelioid and spindle cell tumor: A case series.
November 2023, Journal of cutaneous pathology,
Copied contents to your clipboard!